Cargando…
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
BACKGROUND & AIMS: Increasing evidence highlights dietary fructose as a major driver of non-alcoholic fatty liver disease (NAFLD) pathogenesis, the majority of which is cleared on first pass through the hepatic circulation by enzymatic phosphorylation to fructose-1-phosphate via the ketohexokina...
Autores principales: | Shepherd, Emma L., Saborano, Raquel, Northall, Ellie, Matsuda, Kae, Ogino, Hitomi, Yashiro, Hiroaki, Pickens, Jason, Feaver, Ryan E., Cole, Banumathi K., Hoang, Stephen A., Lawson, Mark J., Olson, Matthew, Figler, Robert A., Reardon, John E., Nishigaki, Nobuhiro, Wamhoff, Brian R., Günther, Ulrich L., Hirschfield, Gideon, Erion, Derek M., Lalor, Patricia F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807164/ https://www.ncbi.nlm.nih.gov/pubmed/33490936 http://dx.doi.org/10.1016/j.jhepr.2020.100217 |
Ejemplares similares
-
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction
por: Gutierrez, Jemy A., et al.
Publicado: (2021) -
Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging
por: Tee, Sui Seng, et al.
Publicado: (2022) -
GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase
por: Liang, Roger J., et al.
Publicado: (2021) -
Ketohexokinase-dependent metabolism of cerebral endogenous fructose in microglia drives diabetes-associated cognitive dysfunction
por: Li, Yansong, et al.
Publicado: (2023) -
Ketohexokinase-A acts as a nuclear protein kinase that mediates fructose-induced metastasis in breast cancer
por: Kim, Jiyoung, et al.
Publicado: (2020)